rs16872911
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001277115.2(DNAH11):c.8797+20T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,612,870 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0028 ( 17 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 94 hom. )
Consequence
DNAH11
NM_001277115.2 intron
NM_001277115.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0580
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 7-21749821-T-G is Benign according to our data. Variant chr7-21749821-T-G is described in ClinVar as [Benign]. Clinvar id is 257936.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-21749821-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0675 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00281 AC: 428AN: 152176Hom.: 17 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
428
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00639 AC: 1582AN: 247648 AF XY: 0.00580 show subpopulations
GnomAD2 exomes
AF:
AC:
1582
AN:
247648
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00162 AC: 2373AN: 1460576Hom.: 94 Cov.: 30 AF XY: 0.00155 AC XY: 1127AN XY: 726378 show subpopulations
GnomAD4 exome
AF:
AC:
2373
AN:
1460576
Hom.:
Cov.:
30
AF XY:
AC XY:
1127
AN XY:
726378
Gnomad4 AFR exome
AF:
AC:
9
AN:
33456
Gnomad4 AMR exome
AF:
AC:
10
AN:
44622
Gnomad4 ASJ exome
AF:
AC:
1
AN:
26096
Gnomad4 EAS exome
AF:
AC:
1990
AN:
39674
Gnomad4 SAS exome
AF:
AC:
49
AN:
85972
Gnomad4 FIN exome
AF:
AC:
0
AN:
53392
Gnomad4 NFE exome
AF:
AC:
45
AN:
1111278
Gnomad4 Remaining exome
AF:
AC:
267
AN:
60326
Heterozygous variant carriers
0
117
234
352
469
586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00279 AC: 425AN: 152294Hom.: 17 Cov.: 32 AF XY: 0.00309 AC XY: 230AN XY: 74474 show subpopulations
GnomAD4 genome
AF:
AC:
425
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
230
AN XY:
74474
Gnomad4 AFR
AF:
AC:
0.000408988
AN:
0.000408988
Gnomad4 AMR
AF:
AC:
0.000523013
AN:
0.000523013
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.0736374
AN:
0.0736374
Gnomad4 SAS
AF:
AC:
0.00144988
AN:
0.00144988
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.00007351
AN:
0.00007351
Gnomad4 OTH
AF:
AC:
0.00330813
AN:
0.00330813
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
72
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at